Clinical Trial Update: Comparative Glucose Clamp Study of Wockhardt's Recombinant Insulin Analog Glargine(Glaritus) With Lantus in T1DM [Phase 1]

View source ↗

Summary

Phase 1 glucose clamp study comparing Wockhardt's insulin glargine analog Glaritus with Lantus in type 1 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Glaritus (insulin glargine)
• Lantus (insulin glargine)

Snippet

Sponsor: Wockhardt | Conditions: Type1 Diabetes | Phase 1 | Status: COMPLETED